He should have only received six months' worth of treatment and is now left with devastating and irreversible consequences on his health.

Inqovi for AML treatment ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug ...

SCAC, while rare, is primarily driven by the human papillomavirus (HPV) and accounts for about 85% of all anal cancers. There ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

The man has called for broader workplace reforms, advocating for laws that guarantee full pay during cancer treatment and ...

Lakeside woman with stage 4 breast cancer had treatment canceled, then restored after advocating with doctors.

Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are ...

The FDA accepted the BLA for ivonescimab plus chemotherapy for patients with EGFR-mutated non-small cell lung cancer post-TKI ...

A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve ...

Samantha Smith, 45, was diagnosed with a brain tumour and was told she needed surgery, radiotherapy and long-term chemo - but ...

A social media professional quit his six-figure advertising job after his requests for paid time off during brain cancer ...